Alisa B Busch
Affiliation: Harvard University
- The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disordersAlisa B Busch
Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
Am J Psychiatry 170:180-7. 2013..Whether parity's effects differ by diagnosis is unknown. The authors examined this question in the context of parity implementation in the Federal Employees Health Benefits (FEHB) Program...
- Changes in guideline-recommended medication possession after implementing Kendra's law in New YorkAlisa B Busch
McLean Hospital, 115 Mill St, Mailstop 226, Belmont, MA 02478, USA
Psychiatr Serv 61:1000-5. 2010....
- Changes over time and disparities in schizophrenia treatment qualityAlisa B Busch
Department of Psychiatry, McLean Hospital, Alcohol and Drug Abuse Treatment Program, Belmont, Massachusetts, USA
Med Care 47:199-207. 2009..However, there also have been considerable changes in the delivery of mental health care in the public sector, as well as increasing state concerns about Medicaid cost containment...
- Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophreniaStacie B Dusetzina
Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
Psychiatr Serv 64:83-7. 2013..S. Food and Drug Administration (FDA) communication and consensus statement warning of the drug's increased metabolic risks, but whether declines differed by racial-ethnic groups is unknown...
- Racial and ethnic disparities in postpartum depression care among low-income womenKaty Backes Kozhimannil
Department of Population Medicine, Harvard Medical School, and Harvard Pilgrim Health Care Institute, Boston, MA, USA
Psychiatr Serv 62:619-25. 2011..The goal of this study was to characterize racial-ethnic differences in mental health care utilization associated with postpartum depression in a multiethnic cohort of Medicaid recipients...
- Changes in the quality of care for bipolar I disorder during the 1990sAlisa B Busch
Alcohol and Drug Abuse Treatment Program, McLean Hospital, Proctor Building, 115 Mill St, Belmont, MA 02478, USA
Psychiatr Serv 58:27-33. 2007..This study estimated changes during the 1990s in the quality of usual-care treatment among persons diagnosed as having bipolar I disorder in a privately insured population...
- Quality of care in a Medicaid population with bipolar I disorderAlisa B Busch
Alcohol and Drug Abuse Treatment Program, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA
Psychiatr Serv 58:848-54. 2007..This study examined whether presenting diagnosis and treatment in intensive settings (hospitalization, partial hospitalization, or residential programs) are correlated with the subsequent treatment of bipolar I disorder...
- Bipolar-I depression outpatient treatment quality and costs in usual care practiceAlisa B Busch
Department of Health Care Policy, Harvard Medical School, MA, USA
Psychopharmacol Bull 41:24-39. 2008..To examine the longitudinal usual care quality and costs of bipolar-I depression treatment in adults...
- Schizophrenia, co-occurring substance use disorders and quality of care: the differential effect of a managed behavioral health care carve-outAlisa B Busch
Alcohol and Drug Abuse Treatment Program and the Department of Health Care Policy, McLean Hospital and Harvard Medical School, Proctor Building, 115 Mill St, Belmont, MA 02446, USA
Adm Policy Ment Health 33:388-97. 2006..Most pronounced across both populations were decrements in receiving the psychosocial treatments for enrollees in the CO arrangement...
- Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-I disorderAlisa B Busch
Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, Massachusetts 02478, USA
Med Care 47:1217-28. 2009..To examine racial/ethnic longitudinal disparities in antimanic medication use among adults with bipolar-I disorder...
- Ten-year trends in quality of care and spending for depression: 1996 through 2005Catherine A Fullerton
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
Arch Gen Psychiatry 68:1218-26. 2011....
- Bipolar-I patient characteristics associated with differences in antimanic medication prescribingAlisa B Busch
McLean Hospital, Belmont, MA, USA
Psychopharmacol Bull 42:35-49. 2009..We studied the association between patient characteristics and patient-reported antimanic medication use upon entry in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)...
- Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisoryStacie B Dusetzina
Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
Pharmacoepidemiol Drug Saf 21:1251-60. 2012..We examine subsequent changes in incident and prevalent SGA use among individuals with severe mental illness...
- The impact of parity on major depression treatment quality in the Federal Employees' Health Benefits Program after parity implementationAlisa B Busch
Department of Psychiatry, Harvard Medical School, McLean Hospital, Alcohol and Drug Abuse Treatment Program, Belmont, Massachusetts 02478, USA
Med Care 44:506-12. 2006..Major depressive disorder (MDD) is a prevalent but often undetected and undertreated and thus could potentially benefit from parity implementation...
- The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusionCatherine A Fullerton
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02478, USA
Med Care 48:372-9. 2010..The case of gabapentin use in bipolar disorder provides an opportunity to study the roles of marketing, clinical evidence, and prior authorization (PA) policy on off-label medication use...
- Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care SystemsAlisa B Busch
McLean Hospital, Mailstop 226, 115 Mill St, Belmont, MA 02478, USA
J Ment Health Policy Econ 18:115-24. 2015..Examining health care system characteristics possibly associated with 30-day readmission may reveal opportunities to improve healthcare quality as well as reduce costs...
- Accurately predicting bipolar disorder mood outcomes: implications for the use of electronic databasesAlisa B Busch
McLean Hospital, Belmont, MA 02478, USA
Med Care 50:311-9. 2012..Monitoring mental health treatment outcomes for populations requires an understanding as to which patient information is needed in electronic format and is feasible to obtain in routine care...
- Antidepressant reformulations: who uses them, and what are the benefits?Haiden A Huskamp
Health Care Policy, Harvard Medical School in Boston, Massachusetts, USA
Health Aff (Millwood) 28:734-45. 2009..We found some evidence of benefit for subgroups of antidepressant users, although benefits varied across reformulations...
- Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes?Alistair J O'Malley
Department of Biomedical Data Science and The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH Department of Health Care Policy, Harvard Medical School, Boston, MA Office of Research and Methodology, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD McLean Hospital, Belmont, MA Department of Psychiatry, Harvard Medical School, Boston, MA
Med Care 53:989-95. 2015..Possibly there are RCT site characteristics that distinguish RCT outcomes from those that can be expected in non-RCT settings...
- Predicting Participation in Psychiatric Randomized Controlled Trials: Insights From the STEP-BDAlisa B Busch
Dr Busch and Ms Zelevinsky are with the Department of Health Care Policy, Harvard Medical School, Boston e mail, where Dr He was affiliated when this work was done Dr Busch is also with McLean Hospital, Belmont, Massachusetts Dr He is now with the Office of Research and Methodology, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland Dr O Malley is with the Dartmouth Institute of Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire
Psychiatr Serv 66:817-23. 2015..This study examined whether RCT participants differ from non-RCT participants who are recruited from the same patient and provider population...
- The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophreniaAlisa B Busch
Department of Psychiatry, Harvard Medical School, Boston, MA, USA
Arch Gen Psychiatry 61:442-8. 2004..The evidence on quality impacts is limited and suggests comparable quality overall, except that people with severe psychiatric disorders may be those most disadvantaged by MBHCOs...